---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-135890"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T04:08:25.718942+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aptevo raises up to $6.2M via warrant exercise inducement; issues new warrants at $9.53

## Summary
- Holders exercise up to 823,544 existing warrants at $7.50/share for ~$6.2M gross proceeds.
- Company issues new warrants to buy 200% of shares exercised at $9.53, 5-year term.
- Roth Capital gets 7% advisory fee; proceeds used for working capital.
- Resale registration statement for new warrant shares due by Dec. 27, 2024.

## SEC filing metadata
- accession: 0000950170-24-135890
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017024135890/0000950170-24-135890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017024135890/apvo-20241212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-135890
- JSON: https://secwatch.observer/filing/0000950170-24-135890.json
- Plain text: https://secwatch.observer/filing/0000950170-24-135890.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.